GCM
EOLS icon

Graham Capital Management’s Evolus EOLS Stock Holding History

Graham Capital Management’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,239
Closed -$223K – 1348
2025
Q2 		$223K Sell
24,239
-33,455
-58% -$342K ﹤0.01% 1087
2025
Q1 		$694K Buy
57,694
+10,731
+23% +$140K 0.01% 670
2024
Q4 		$518K Buy
46,963
+34,907
+290% +$491K 0.01% 725
2024
Q3 		$195K Sell
12,056
-5,138
-30% -$71.8K ﹤0.01% 918
2024
Q2 		$187K Buy
17,194
+939
+6% +$11.6K ﹤0.01% 876
2024
Q1 		$228K Sell
16,255
-8,239
-34% -$107K ﹤0.01% 865
2023
Q4 		$258K Sell
24,494
-13,452
-35% -$120K 0.01% 766
2023
Q3 		$347K Buy
37,946
+11,438
+43% +$103K 0.01% 675
2023
Q2 		$193K Buy
+26,508
New +$229K 0.01% 830
2022
Q4 		– Sell
-11,805
Closed -$95K – 1110
2022
Q3 		$95K Buy
+11,805
New +$125K ﹤0.01% 1027
2022
Q2 		– Sell
-26,082
Closed -$292K – 1074
2022
Q1 		$292K Buy
+26,082
New +$222K 0.01% 741

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Graham Capital Management's EOLS Position: Q3 2025 in Review

Graham Capital Management sold out of Evolus (EOLS) in Q3 2025, closing a stake of 24,239 shares — an estimated $223K sold.

Graham Capital Management first reported a position in EOLS in Q1 2022 and held it in 11 quarters. The position peaked at $694K in Q1 2025. 160 funds tracked by Wall St. Rank hold EOLS as of Q3 2025.

  • Graham Capital Management reported no remaining Evolus position as of Q3 2025 after selling out during the quarter.
  • Graham Capital Management sold 24,239 Evolus shares in Q3 2025, an estimated $223K.
  • Graham Capital Management first reported a position in Evolus in Q1 2022 and held it in 11 quarters.
  • Graham Capital Management's Evolus position peaked at $694K in Q1 2025.
  • 160 funds tracked by Wall St. Rank held Evolus as of Q3 2025.

Based on Graham Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.